Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

Completed

• Conditions: Head and Neck Cancer

• Registration Number: NCT00180245
• Lead Sponsor: Technische Universität Dresden

Brief Summary

The purpose of the study is to describe the regional and global FDG-kinetics in head and neck cancer during percutaneous radiation therapy.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-07
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-16
• Primary Completion: 2015-12
• Study Completion: 2015-12
• Status Verified: 2016-03
• Last Update Submitted: 2016-03-15
• Last Update Posted: 2016-03-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

• Histologically confirmed head and neck cancer not curable by surgery
• Karnofsky > 70%
• Tumor volume and localization allow curative radiotherapy
• Written consent

Exclusion Criteria

• Metastases
• Earlier radiotherapy of head or neck
• Pregnancy
• Secondary malignancy excluding dermal carcinoma T1 and Tis-carcinoma of cervix uteri
• Psychiatric impairment

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Department of Nuclear Medicine; 🇩🇪 Dresden, Germany